ZhenBin Ding

8PUBLICATIONS
10CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsHaematological tumoursMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 02, 2026
Combined MEK1/2 and Autophagy Inhibition Suppresses Tumor Growth via STING-Mediated Type I Interferon Response in iCCA.

|Aug 20, 2025
First-line tislelizumab and ociperlimab combined with gemcitabine and cisplatin in advanced biliary tract cancer (ZSAB-TOP): a multicenter, single-arm, phase 2 study.

Guoming Shi, Xiaoyong Huang, Liang Ma

|Nov 21, 2023
Single-cell and spatial architecture of primary liver cancer.

Pei-Yun Zhou, Cheng Zhou, Wei Gan

|Mar 06, 2023
CD36+ cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor.

Gui-Qi Zhu, Zheng Tang, Run Huang

|Jan 17, 2023
A RIPK3-independent role of MLKL in suppressing parthanatos promotes immune evasion in hepatocellular carcinoma.

Xifei Jiang, Wenjia Deng, Siyao Tao

|Nov 21, 2022
Effectiveness and Safety of Avatrombopag in Liver Cancer Patients with Severe Thrombocytopenia: Real-World Data and Challenges.

Ao Huang, Jia-Feng Chen, Jian-Zhang Wu

Pageof 2

Frequent Collaborators

5 joint publications

Jian Zhou

4 joint publications

Jia Fan

1 joint publications

Pei-Yun Zhou

1 joint publications

Bao-Ye Sun